320 related articles for article (PubMed ID: 20813012)
1. Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development.
Lee-Sherick AB; Linger RM; Gore L; Keating AK; Graham DK
Br J Haematol; 2010 Nov; 151(4):295-311. PubMed ID: 20813012
[TBL] [Abstract][Full Text] [Related]
2. Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia.
Irving JA
Br J Haematol; 2016 Mar; 172(5):655-66. PubMed ID: 26568036
[TBL] [Abstract][Full Text] [Related]
3. Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia.
Morley NJ; Marks DI
Expert Rev Anticancer Ther; 2016; 16(2):159-64. PubMed ID: 26654587
[TBL] [Abstract][Full Text] [Related]
4. Management of relapsed acute lymphoblastic leukemia in childhood with conventional and innovative approaches.
Locatelli F; Moretta F; Rutella S
Curr Opin Oncol; 2013 Nov; 25(6):707-15. PubMed ID: 24076579
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase inhibitors in Ph+ acute lymphoblastic leukaemia: facts and perspectives.
Malagola M; Papayannidis C; Baccarani M
Ann Hematol; 2016 Apr; 95(5):681-93. PubMed ID: 26891878
[TBL] [Abstract][Full Text] [Related]
6. Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia.
Dinner S; Lee D; Liedtke M
Leuk Lymphoma; 2014 Aug; 55(8):1715-24. PubMed ID: 24251864
[TBL] [Abstract][Full Text] [Related]
7. Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia.
Yuan N; Song L; Zhang S; Lin W; Cao Y; Xu F; Fang Y; Wang Z; Zhang H; Li X; Wang Z; Cai J; Wang J; Zhang Y; Mao X; Zhao W; Hu S; Chen S; Wang J
Haematologica; 2015 Mar; 100(3):345-56. PubMed ID: 25512644
[TBL] [Abstract][Full Text] [Related]
8. Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.
Tasian SK; Hunger SP
Br J Haematol; 2017 Mar; 176(6):867-882. PubMed ID: 27984637
[TBL] [Abstract][Full Text] [Related]
9. Dual targeting of Hsp90 in childhood acute lymphoblastic leukaemia.
Diamanti P; Cox CV; Moppett JP; Blair A
Br J Haematol; 2018 Jan; 180(1):147-149. PubMed ID: 27503106
[No Abstract] [Full Text] [Related]
10. Emerging biological therapies to treat acute lymphoblastic leukemia.
Huguet F; Tavitian S
Expert Opin Emerg Drugs; 2017 Mar; 22(1):107-121. PubMed ID: 27820973
[TBL] [Abstract][Full Text] [Related]
11. Precision medicine approaches may be the future for CRLF2 rearranged Down Syndrome Acute Lymphoblastic Leukaemia patients.
Page EC; Heatley SL; Yeung DT; Thomas PQ; White DL
Cancer Lett; 2018 Sep; 432():69-74. PubMed ID: 29879498
[TBL] [Abstract][Full Text] [Related]
12. Acute lymphoblastic leukaemia.
Pui CH; Robison LL; Look AT
Lancet; 2008 Mar; 371(9617):1030-43. PubMed ID: 18358930
[TBL] [Abstract][Full Text] [Related]
13. Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence.
Bleckmann K; Schrappe M
Br J Haematol; 2016 Mar; 172(6):855-69. PubMed ID: 26773444
[TBL] [Abstract][Full Text] [Related]
14. Novel drug targets in acute leukemia.
Stock W
Clin Adv Hematol Oncol; 2015 Aug; 13(8):493-5. PubMed ID: 26351809
[No Abstract] [Full Text] [Related]
15. [A brief history of treatments for childhood acute lymphoblastic leukaemia].
Leverger G; Baruchel A; Schaison G
Bull Acad Natl Med; 2009 Oct; 193(7):1495-9; discussion 1499-500. PubMed ID: 20669630
[TBL] [Abstract][Full Text] [Related]
16. New agents in the treatment of acute lymphocytic leukaemia.
Thomas DA; Cortes J; Kantarjian HM
Best Pract Res Clin Haematol; 2002 Dec; 15(4):771-90. PubMed ID: 12617876
[TBL] [Abstract][Full Text] [Related]
17. Advances in childhood leukaemia: successful clinical-trials research leads to individualised therapy.
Ziegler DS; Dalla Pozza L; Waters KD; Marshall GM
Med J Aust; 2005 Jan; 182(2):78-81. PubMed ID: 15651967
[TBL] [Abstract][Full Text] [Related]
18. Notch signaling as a therapeutic target for acute lymphoblastic leukemia.
Bellavia D; Palermo R; Felli MP; Screpanti I; Checquolo S
Expert Opin Ther Targets; 2018 Apr; 22(4):331-342. PubMed ID: 29527929
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapy paves the way for the cure of acute lymphoblastic leukaemia.
Rafei H; Kantarjian HM; Jabbour EJ
Br J Haematol; 2020 Jan; 188(2):207-223. PubMed ID: 31566728
[TBL] [Abstract][Full Text] [Related]
20. Asparaginase in the management of adult acute lymphoblastic leukaemia: is it used appropriately?
Patil S; Coutsouvelis J; Spencer A
Cancer Treat Rev; 2011 May; 37(3):202-7. PubMed ID: 20822851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
